Healthcare

Japan Pharmaceutical Market Japan is one of the largest pharmaceutical markets in the world. According to the Annual Pharmaceutical Production Statistics, published by Ministry of Health, Labor and Welfare (MHLW)’s, the Japanese market for prescription and nonprescription pharmaceuticals in 2019 accounted for US$ 105 Billion. Prescription pharmaceuticals comprise of approximately 90 % of the total… [Continue Reading]

Ronapreve – First Drug F. Hoffmann-La Roche AG on July 2021, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved ‘Ronapreve’ which is a combination of casirivimab and imdevimab – for the treatment with mild to moderate COVID-19 patients via intravenous route of drug administration. The antibody combination was granted a ‘Special Approval… [Continue Reading]

Merck & Co. First Oral COVID Drug Merck & Co., which is headquartered, has applied for state approval for the production and sale of an oral COVID-19 drug. The company has received the granted for the first such pill to be used in Japan. The Japan Ministry of Health, Labor and Welfare are the under… [Continue Reading]

Japanese Pharmaceuticals Company Japanese pharmaceuticals company – Mitsubishi Tanabe Pharma Corporation – a subsidiary of Mitsubishi Chemical Holdings Corporation, launched its first plant to produce Covid-19 vaccine in the world. The vaccine is in the development phase at Osaka-based company’s subsidiary Medicago from a plant from the tobacco family by December 2021. The vaccines produced… [Continue Reading]

Japan Healthcare and Reimbursement System Japan’s healthcare system is a robust & well-funded public as well as private insurance and reimbursement system. All medical device products/equipment must be approved for listing in Japan’s reimbursement system. Japan relies on a universal and cost-efficient healthcare system. All Japanese citizens are made mandatory to join the health insurance… [Continue Reading]

Japan: Cosmetics Market Overview Japan – is the 2nd largest market for cosmetics and personal care products. Japanese cosmetics manufacturers are competitive and sophisticated. Japanese consumers are known to be highly conscious of quality, product value, and the brands they buy and use. Made-in-Japan products of cosmetics are popular and have wider presence and stable… [Continue Reading]

Plastic Surgeries During the COVID-19 Pandemic Period Scarcities of medical materials, manufacturing and consumer goods caused by the COVID-19 pandemic had quickly became a major issue in Japan. Deficiencies of personal protective equipment (PPE), such as medical masks and gloves, face shields, and sanitizing products, along with hospital beds, ICU beds, oxygen therapy equipment, ventilators,… [Continue Reading]

Remote Health Diagnosis and Monitoring is Blooming in Japan Coronavirus disease also known as COVID-19, is caused by severe acute respiratory syndrome coronavirus 2 (i.e. SARS-CoV-2) that has rapidly spread worldwide. It is a new illness that initially affected people in Wuhan, China, and later to the other parts of the globe. Remote health diagnosis… [Continue Reading]

The outbreak of COVID-19 and the resulting social activity restrictions have rigorously impacted Pharmaceutical Products-drug research and development. Japanese pharmaceutical companies, including Daiichi Sankyo Co Ltd, Takeda Pharmaceutical Co Ltd., The Chugai Pharmaceutical Co., Ltd, Astellas Pharma Inc., and others engaged in the development of numerous drugs, were affected by these unprecedented circumstances. Moreover, due… [Continue Reading]

Japan is the economic powerhouse. The rapidly aging population is having enormous consequences on the already stretched healthcare system. More sophisticated medical devices and numerous automation, including robotics, are some solutions needed to tackle the issue. Japan is also known as a technological hub. Japan is the very robust domestic manufacturing industry & market such… [Continue Reading]